Cong M et al. – The study showed that irbesartan may induce angiogenic effects in vascular endothelial cells. It suggested that the mechanism of angiogenic effects of Angiotensin II type 1 receptor blockers might be attributed to the signaling cascade from angiotensin receptors in the VEGF pathway. It also provided evidence indicating that Angiotensin II type 1 receptor blockers could be used as a novel therapeutic approach to treat chronic ischemic heart disease as well as anti–hypertensive agents. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close